This EACVI survey aims to explore the real-world use of advanced invasive and non-invasive cardiovascular imaging in patients with a working diagnosis of MINOCA. Your responses will help identify current practice patterns, barriers to imaging access and implementation, and opportunities to improve diagnostic pathways and patient management.
Thank you for participating in this EACVI survey
May we remind you of the codes of conduct related to market research among healthcare professionals:
• The survey is anonymous
• You have the right to end your participation in this survey at any time
• We comply with the European General Data Protection Regulation (GDPR) 2016/679.
Any personal data processed in connection with this survey will be treated confidentially and only used for the purposes of market research. Material and data collected from you will be analysed overall, used internally by the ESC and kept for a maximum of 24 months for analysis and quality control purposes. We take all reasonable care to prevent any unauthorised access to your personal data. We respect your privacy and your right to access, modify, or suppress your personal data. At any time, you can ask to know what personal data is being held.
If you have any questions about data protection or require further information, please contact our data protection officer DPO@escardio.org

Question Title

1. May we please ask you to confirm you have read the clauses above and accept participation in this survey

Section 1 – Demographics and clinical background

Question Title

2. In which Country do you practice?

Question Title

3. What is your age range?

Question Title

4. Are you?

Question Title

5. In which healthcare system do you mainly work?

Question Title

6. What is your primary subspecialty?

Section 2- Availability and Access to Advanced Imaging Modalities

Question Title

7. Which imaging modalities can you access in your institution? (select all that apply)

Question Title

8. If invasive intracoronary imaging/function testing is not available in your centre, is referral to another centre feasible within the same healthcare system?

Question Title

9. If CMR is not available in your centre, is referral to another centre feasible within the same healthcare system?

Question Title

10. What is the typical waiting time for CMR in patients with suspected MINOCA?

Question Title

11. Are parametric mapping sequences (T1/T2/ECV) available in your centre?

Question Title

12. Is stress CMR quantitative perfusion mapping available in your centre?

Question Title

13. Is late iodine enhancement imaging with cardiac CT available in your centre?

Section 3 – Actual Clinical Practice/ Local Diagnostic Pathway

Question Title

14. Does your centre have a standardised diagnostic protocol for patients with suspected MINOCA?

Question Title

15. In patients with suspected MINOCA at invasive coronary angiography, do you perform additional invasive tests such as intracoronary imaging or invasive functional coronary testing?

Question Title

16. When do you mostly perform invasive functional assessment and/or intracoronary imaging in patients with suspected MINOCA?

Question Title

17. If your patient with suspected MINOCA is female, would this influence your use of the following diagnostic tests (select all that apply)?

Question Title

18. In your centre, the choice of the first non-invasive imaging modality used in suspected MINOCA is mainly driven by: (up to 3 answers) (Required.)

Question Title

19. In your practice, what CMR implementation challenges/barriers do you face? (select all that apply, up to 3 answers) (Required.)

Question Title

20. In your clinical practice, how often do CMR findings in patients with suspected MINOCA lead to a revision of the initial diagnosis based on clinical presentation?

Question Title

21. In your clinical practice, how often do CMR findings change patient’s management, including therapy?

Question Title

22. In patients with a final diagnosis of MINOCA, how often do you request follow-up CMR?

Question Title

23. Who is the main CMR reporting physician in your hospital?

Question Title

24. Does the cardiologist reporting physician hold a certification for CMR reporting? (select all that apply)

Question Title

25. Does the radiologist reporting physician hold a certification for CMR reporting? (select all that apply)

Question Title

26. In your centre, are MINOCA cases discussed in a multidisciplinary meeting including clinical cardiologists, interventional cardiologists, cardiac imagers, and radiologists?

Section 4 – Perceived utility of modalities and strategies of implementation

Question Title

27. Which of the following invasive tests do you find most useful to investigate a patient with a MINOCA working diagnosis? (1-first choice, 5-last choice)

Question Title

28. In patients with a working diagnosis of MINOCA, which is the next non-invasive test you consider most useful after confirmation of unobstructed coronary arteries at invasive angiography?

Question Title

29. If the waiting list is too long (>2 weeks from index event), do you still find it useful to refer a patient with a MINOCA working diagnosis for CMR? (choose only 1 option, the most important to you)

Question Title

30. What strategy do you think will be the most useful to implement CMR use? (select all that apply, up to 3 answers) (Required.)

Question Title

31. In your opinion, is a hub-and-spoke diagnostic network for MINOCA feasible in your healthcare system?

Question Title

32. Which barriers most limit the implementation of a structured MINOCA network? (up to 3 answers) (Required.)

Question Title

33. Which patients with suspected MINOCA should preferentially be referred to specialised hub centres?

Question Title

34. Additional comments

T